Local regulation of implantation at the human fetal-maternal interface

被引:96
作者
Dimitriadis, Evdokia [1 ]
Nie, Guiying [1 ]
Hannan, Natalie J. [1 ]
Paiva, Premila [1 ]
Salamonsen, Lois A. [1 ]
机构
[1] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
基金
英国医学研究理事会;
关键词
PC6; LIF; IL-11; chemokine; trophoblast; endometrium; LEUKEMIA INHIBITORY FACTOR; PRO-PROTEIN CONVERTASES; HUMAN ENDOMETRIUM; PROPROTEIN CONVERTASE; EMBRYO IMPLANTATION; GENE-EXPRESSION; FACTOR LIF; LEUKOCYTE RECRUITMENT; EXTRACELLULAR-MATRIX; RECEPTOR EXPRESSION;
D O I
10.1387/ijdb.082772ed
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Embryo implantation and formation of a functional placenta are complex processes that require a plethora of regulatory molecules. In recent years, many of these mediators have been identified, often from studies in experimental animals. Furthermore, their expression patterns at the embryo-maternal interface in women have been characterized and provide clues to their potential actions. What has been missing in most cases is any experimental demonstration of their function. Proteases, cytokines and chemokines are among the molecules identified at the embryo-maternal interface. Functional studies of the protease, proprotein convertase (PC)6, the gp130 cytokines, leukemia inhibitory factor (LIF) and interleukin (IL)11 and the chemokines, CX3CL1 and CCL14 demonstrate potential actions within the uterine cavity. These actions include: enhancing blastocyst development, modifying adhesive properties of the blastocyst and the uterine epithelial surface, and providing chemotactic guidance to the blastocyst. As implantation proceeds, PC6 and IL-11 also act to drive decidualization. The products (proteases, chemokines and cytokines) produced by these decidual cells provide a unique environment. This is important for both directing and restraining trophoblast invasion and for leukocyte trafficking into the decidua until the placenta is fully established.
引用
收藏
页码:313 / 322
页数:10
相关论文
共 91 条
[31]   Cutting back on pro-protein convertases:: the latest approaches to pharmacological inhibition [J].
Fugère, M ;
Day, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (06) :294-301
[32]   MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: In vitro evidence that MUC16 is a barrier to trophoblast adherence [J].
Gipson, Ilene K. ;
Blalock, Timothy ;
Tisdale, Ann ;
Spurr-Michaud, Sandra ;
Allcorn, Sara ;
Stavreus-Evers, Anneli ;
Gemzell, Kristina .
BIOLOGY OF REPRODUCTION, 2008, 78 (01) :134-142
[33]   Elucidating endometrial function in the post-genomic era [J].
Giudice, LC .
HUMAN REPRODUCTION UPDATE, 2003, 9 (03) :223-235
[34]   Roles of the insulinlike growth factor family in nonpregnant human endometrium and at the Decidual: Trophoblast interface [J].
Giudice, LC ;
Irwin, JC .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1999, 17 (01) :13-21
[35]   CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: Potential roles in human embryo implantation [J].
Hannan, Natalie J. ;
Salamonsen, Lois A. .
BIOLOGY OF REPRODUCTION, 2008, 79 (01) :58-65
[36]   Role of chemokines in the endometrium and in embryo implantation [J].
Hannan, Natalie J. ;
Salamonsen, Lois A. .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (03) :266-272
[37]   Models for Study of Human Embryo Implantation: Choice of Cell Lines? [J].
Hannan, Natalie J. ;
Paiva, Premila ;
Dimitriadis, Evdokia ;
Salamonsen, Lois A. .
BIOLOGY OF REPRODUCTION, 2010, 82 (02) :235-245
[38]   The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface [J].
Hannan, NJ ;
Jones, RL ;
White, CA ;
Salamonsen, LA .
BIOLOGY OF REPRODUCTION, 2006, 74 (05) :896-904
[39]   Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling [J].
Hannan, NJ ;
Jones, RL ;
Critchley, HOD ;
Kovacs, GJ ;
Rogers, PAW ;
Affandi, B ;
Salamonsen, LA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6119-6129
[40]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314